What Trump’s New Drug Pricing Deal Means for People With Obesitynews2025-11-06T21:53:59+00:00November 6th, 2025|The New York Times|
F.D.A. Drug Unit Chief Resigns, and Is Sued by Drug Companynews2025-11-03T03:40:45+00:00November 3rd, 2025|The New York Times|
F.D.A. Moves to Speed Approvals for Cheaper Copycat Drugsnews2025-10-29T20:07:07+00:00October 29th, 2025|The New York Times|
Texas demanda a los fabricantes de Tylenol por supuesto encubrimiento de riesgos de autismonews2025-10-28T16:54:47+00:00October 28th, 2025|The New York Times|
Texas Sues Tylenol Makers, Claiming They Hid Autism Risksnews2025-10-28T12:24:44+00:00October 28th, 2025|The New York Times|
FDA Approves New Menopause Drug to Treat Hot Flashes and Night Sweatsnews2025-10-24T17:48:59+00:00October 24th, 2025|The New York Times|
Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Pricesnews2025-10-23T09:00:45+00:00October 23rd, 2025|The New York Times|
Un decano de Harvard cobró 150.000 dólares como perito en las demandas contra Tylenolnews2025-09-24T18:51:33+00:00September 24th, 2025|The New York Times|
F.D.A.’s Approval of a Drug for Autism Upends Review Processnews2025-09-23T23:09:46+00:00September 23rd, 2025|The New York Times|
Harvard Dean Was Paid $150,000 as an Expert Witness in Tylenol Lawsuitsnews2025-09-23T21:57:24+00:00September 23rd, 2025|The New York Times|
